By the end of 2018, through 10 years of continuous research and development, we have successfully developed : Small molecule targeted anti-tumor products: 21 projects ,such as Gefitinib, Erlotinib, Pazopanib, Lapatinib, Afatinib, Lenvatinib,etc; Diabetes products: 16 items ,such as Sitagliptin, Linagliptin,Alogliptin, Dapagliflozin, and Canagliflozin,etc; Anti-Cardiovascular products: 7 projects ,including Apixaban, Rivaroxaban, Betrixaban, and Dofetilide;
ANQING CHICO PHARMACEUTICAL CO.,LTD.
Country: 
China (Mainland)
Business Type: Trading Company
Premiumsupplier
Ms.JIANG
Tel: +86-13057662806
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)anilineCAS NO.: 641571-11-1
3-Dimethylaminopropylchloride hydrochlorideCAS NO.: 5407-04-5
5-Bromo-4-methoxy-2-methylbenzoicacidCAS NO.: 875245-69-5
2-({(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dioneCAS NO.: 446292-08-6
6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazoleCAS NO.: 1231930-33-8
Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl esterCAS NO.: 27143-07-3
4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazolineCAS NO.: 196603-96-0
tert-Butyl 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylateCAS NO.: 1032903-63-1
Methyl 3-((2,6-difluorophenyl)sul fonamido)-2-fluorobenzoateCAS NO.: 1195768-19-4
N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMineCAS NO.: 1421372-94-2
